Both conditions also contribute to metabolic dysregulation, with CKD altering lipid profiles, increasing insulin resistance, and disturbing calcium-phosphorus balance, while sarcopenia reduces metabolic flexibility, worsening hyperglycemia and metabolic stress [23, 24]. This evidence concerns the gene INS and chronic kidney disease.